{"id":"https://openalex.org/W2390700274","doi":"https://doi.org/10.1016/j.eurpsy.2016.01.1374","title":"Between Scylla and Charybdis: Where does the treatment of Addison's disease in late-life depression go first?","display_name":"Between Scylla and Charybdis: Where does the treatment of Addison's disease in late-life depression go first?","alternate_titles":[],"publication_year":2016,"publication_date":"2016-03-01","ids":{"openalex":"https://openalex.org/W2390700274","doi":"https://doi.org/10.1016/j.eurpsy.2016.01.1374","mag":"2390700274"},"language":"en","primary_location":{"id":"doi:10.1016/j.eurpsy.2016.01.1374","doi":"https://doi.org/10.1016/j.eurpsy.2016.01.1374","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.eurpsy.2016.01.1374","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/E0CEE75483B5770DE4F65A34501E5051/S0924933800231519a.pdf/div-class-title-between-scylla-and-charybdis-where-does-the-treatment-of-addison-s-disease-in-late-life-depression-go-first-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2390700274"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/E0CEE75483B5770DE4F65A34501E5051/S0924933800231519a.pdf/div-class-title-between-scylla-and-charybdis-where-does-the-treatment-of-addison-s-disease-in-late-life-depression-go-first-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017802426","display_name":"Sergei I. Petrykiv","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133565","display_name":"GGZ Friesland","ror":"https://ror.org/03c0kv729","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133565"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"S. Petrykiv","raw_affiliation_strings":["GGZ Friesland, Emergency Psychiatry, Leeuwarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GGZ Friesland, Emergency Psychiatry, Leeuwarden, Netherlands","institution_ids":["https://openalex.org/I4210133565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028054308","display_name":"Mara Arts","orcid":"https://orcid.org/0000-0001-9225-7134","observed_orcids":["https://orcid.org/0000-0001-9225-7134"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Arts","raw_affiliation_strings":["UMC Groningen, Old Age Psychiatry, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UMC Groningen, Old Age Psychiatry, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085440566","display_name":"Linda de Jonge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. de Jonge","raw_affiliation_strings":["UMC Groningen, Epidemiology, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UMC Groningen, Epidemiology, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5017802426"],"corresponding_institution_ids":["https://openalex.org/I4210133565"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"S1","first_page":"S382","last_page":"S382"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/addison-s-disease","display_name":"Addison's disease","score":1.0},{"id":"https://openalex.org/keywords/geriatric-depression","display_name":"geriatric depression","score":0.9509999752044678},{"id":"https://openalex.org/keywords/glucocorticoid-replacement-therapy","display_name":"glucocorticoid replacement therapy","score":0.921999990940094},{"id":"https://openalex.org/keywords/adrenal-insufficiency","display_name":"adrenal insufficiency","score":0.9319999814033508},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C2776899810","wikidata":"https://www.wikidata.org/wiki/Q2697578","display_name":"Fludrocortisone","level":3,"score":0.8481541872024536},{"id":"https://openalex.org/C2777817097","wikidata":"https://www.wikidata.org/wiki/Q8282","display_name":"Addison's disease","level":3,"score":0.7360216379165649},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.7236263751983643},{"id":"https://openalex.org/C2780841215","wikidata":"https://www.wikidata.org/wiki/Q422549","display_name":"Glucocorticoid","level":2,"score":0.6685183048248291},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6588034629821777},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.48842233419418335},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.4645063579082489},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.45123040676116943},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4309907555580139},{"id":"https://openalex.org/C2778808452","wikidata":"https://www.wikidata.org/wiki/Q4057453","display_name":"Adrenal crisis","level":3,"score":0.43069350719451904},{"id":"https://openalex.org/C2909972456","wikidata":"https://www.wikidata.org/wiki/Q2507454","display_name":"Adrenocortical Insufficiency","level":3,"score":0.41836827993392944},{"id":"https://openalex.org/C2778709874","wikidata":"https://www.wikidata.org/wiki/Q190875","display_name":"Hydrocortisone","level":2,"score":0.4062904417514801},{"id":"https://openalex.org/C2778129406","wikidata":"https://www.wikidata.org/wiki/Q2507454","display_name":"Adrenal insufficiency","level":2,"score":0.391510009765625},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3772805333137512},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.35298073291778564},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.eurpsy.2016.01.1374","doi":"https://doi.org/10.1016/j.eurpsy.2016.01.1374","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.eurpsy.2016.01.1374","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/E0CEE75483B5770DE4F65A34501E5051/S0924933800231519a.pdf/div-class-title-between-scylla-and-charybdis-where-does-the-treatment-of-addison-s-disease-in-late-life-depression-go-first-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.eurpsy.2016.01.1374","doi":"https://doi.org/10.1016/j.eurpsy.2016.01.1374","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.eurpsy.2016.01.1374","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/E0CEE75483B5770DE4F65A34501E5051/S0924933800231519a.pdf/div-class-title-between-scylla-and-charybdis-where-does-the-treatment-of-addison-s-disease-in-late-life-depression-go-first-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2390700274.pdf","grobid_xml":"https://content.openalex.org/works/W2390700274.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2045897590","https://openalex.org/W207262855","https://openalex.org/W2068025576","https://openalex.org/W3209970172","https://openalex.org/W2156164215","https://openalex.org/W7112692","https://openalex.org/W2415076413","https://openalex.org/W2035917174","https://openalex.org/W173141406","https://openalex.org/W2159798354"],"abstract_inverted_index":{"Introduction":[0],"Older":[1],"adults":[2],"with":[3,22,42,56,90,95,193,206],"adrenocortical":[4],"insufficiency,":[5],"including":[6],"Addison's":[7,68,91,152,194,215],"disease":[8,69,153,195],"(AD),":[9],"are":[10,220],"at":[11],"an":[12,214],"increased":[13],"risk":[14],"for":[15],"developing":[16],"late-life":[17,35,176],"depression.":[18,36],"Treatment":[19],"of":[20,34,44,50,58,67,134,150,166,188,209,229,238],"AD":[21],"glucocorticoid":[23,51,172,202,225],"replacement":[24,173],"therapy":[25,174],"may":[26,31],"exacerbate":[27],"depressive":[28,104,161],"symptoms":[29,105,162],"and":[30,78,103,123,175],"complicate":[32],"treatment":[33,66,187],"Objectives":[37],"To":[38,61],"present":[39],"a":[40,47,63,82],"case":[41,49,74,184],"algorithm":[43],"decision-making":[45],"in":[46,54,70,191,201],"particular":[48],"induced":[52],"depression":[53,177,190],"patient":[55],"syndrome":[57],"Addison.":[59],"Aims":[60],"report":[62,75],"case-study,":[64],"describing":[65],"LLD.":[71],"Methods":[72],"A":[73,86],"is":[76,178,196,208],"presented":[77],"discussed,":[79],"followed":[80],"by":[81,198],"literature":[83],"review.":[84],"Results":[85],"77-year-old":[87],"female,":[88],"diagnosed":[89],"disease,":[92],"was":[93,112,128,139],"referred":[94],"persistent":[96],"fatigue,":[97],"weakness,":[98],"weight":[99],"loss,":[100],"sleep":[101],"disturbances,":[102],"over":[106],"the":[107],"previous":[108],"6":[109],"months.":[110],"She":[111],"taken":[113],"losartan":[114],"100":[115,121],"mg/day,":[116,119],"zolpidem":[117],"10":[118],"fludrocortisone":[120],"\u03bcg/day,":[122],"hydrocortisone":[124],"35":[125],"mg/day.":[126],"There":[127],"no":[129],"personal":[130],"or":[131],"family":[132],"history":[133],"psychiatric":[135],"problems.":[136],"Clinical":[137],"examination":[138],"normal":[140],"aside":[141],"from":[142],"skin":[143],"hyperpigmentation.":[144],"After":[145],"initial":[146],"minimal":[147,199],"dose":[148],"reduction":[149],"glucocorticoids,":[151],"remained":[154],"under":[155],"control.":[156],"One":[157],"week":[158],"later,":[159],"her":[160],"disappeared":[163],"without":[164],"administration":[165],"antidepressants.":[167],"Conclusion":[168],"The":[169,182,231],"association":[170],"between":[171],"not":[179,234],"well":[180],"understood.":[181],"current":[183],"shows":[185],"that":[186],"glucocorticoid-induced":[189],"subjects":[192],"achievable":[197],"adjustments":[200],"regiment.":[203],"However,":[204],"collaboration":[205],"endocrinology":[207],"vital":[210],"importance":[211],"to":[212,222],"prevent":[213],"crisis.":[216],"Pharmacokinetic":[217],"dose-finding":[218],"studies":[219],"required":[221],"find":[223],"optimal":[224],"adjustment":[226],"strategy.":[227],"Disclosure":[228],"interest":[230],"authors":[232],"have":[233],"supplied":[235],"their":[236],"declaration":[237],"competing":[239],"interest.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2390700274","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}
